Ci Investments Inc. Sarepta Therapeutics, Inc. Transaction History
Ci Investments Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Ci Investments Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ci Investments Inc. holds 2,236 shares of SRPT stock, worth $83,246. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,236
Previous 3,139
28.77%
Holding current value
$83,246
Previous $382,000
62.57%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SRPT
# of Institutions
505Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$384 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$337 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$336 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$151 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$125 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.26B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...